In last trading session, Biofrontera Inc (NASDAQ:BFRI) saw 13.48 million shares changing hands with its beta currently measuring 0.27. Company’s recent per share price level of $1.18 trading at $0.07 or 6.31% at ring of the bell on the day assigns it a market valuation of $9.14M. That closing price of BFRI’s stock is at a discount of -138.14% from its 52-week high price of $2.81 and is indicating a premium of 48.31% from its 52-week low price of $0.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.57 million shares which gives us an average trading volume of 2.87 million if we extend that period to 3-months.

For Biofrontera Inc (BFRI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Biofrontera Inc (NASDAQ:BFRI) trade information

Upright in the green during last session for gaining 6.31%, in the last five days BFRI remained trading in the green while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $1.18 price level, adding 36.9% to its value on the day. Biofrontera Inc’s shares saw a change of 8.26% in year-to-date performance and have moved 8.26% in past 5-day. Biofrontera Inc (NASDAQ:BFRI) showed a performance of 18.00% in past 30-days. Number of shares sold short was 0.46 million shares which calculate 0.08 days to cover the short interests.

Biofrontera Inc (BFRI) estimates and forecasts

Statistics highlight that Biofrontera Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 20.43% of value to its shares in past 6 months, showing an annual growth rate of 81.39% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2025.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 7.90% during past 5 years.

Biofrontera Inc (NASDAQ:BFRI)’s Major holders

Insiders are in possession of 32.06% of company’s total shares while institution are holding 20.68 percent of that, with stock having share float percentage of 30.44%. Investors also watch the number of corporate investors in a company very closely, which is 20.68% institutions for Biofrontera Inc that are currently holding shares of the company.